Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for Prevention of Postherpetic Neuralgia
NCT03186443Phase 3Unknown
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Start
- Oct 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pregabalin in postherpetic neuralgia (PHN), sponsored by Second Affiliated Hospital of Guangzhou Medical University. Status: unknown.
02
Drugs
pregabalin
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT03186443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03186443.